Amundi’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58.8K Buy
20,412
+1,282
+7% +$3.26K ﹤0.01% 2045
2026
Q1
$37.5K Buy
+19,130
New +$44.9K ﹤0.01% 1980
2022
Q3
Sell
-185,318
Closed -$1.14M 1860
2022
Q2
$1.14M Buy
185,318
+49,513
+36% +$551K ﹤0.01% 1147
2022
Q1
$2.58M Buy
135,805
+99,168
+271% +$2.27M ﹤0.01% 1084
2021
Q4
$997K Buy
36,637
+14,300
+64% +$575K ﹤0.01% 1296
2021
Q3
$916K Buy
+22,337
New +$810K ﹤0.01% 1307

Other funds holding GDRX

Amundi's GDRX Position: Q2 2026 in Review

Amundi increased its GoodRx Holdings (GDRX) stake by 6.7% in Q2 2026, buying an estimated $3.26K and bringing the position to 20,412 shares worth $58.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2045.

Amundi first reported a position in GDRX in Q3 2021 and has held it in 6 quarters since. The position peaked at $2.58M in Q1 2022. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Amundi held 20,412 shares of GoodRx Holdings worth $58.8K as of Q2 2026.
  • Amundi bought 1,282 GoodRx Holdings shares in Q2 2026, an estimated $3.26K.
  • GoodRx Holdings made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #2045 holding.
  • Amundi first reported a position in GoodRx Holdings in Q3 2021 and has held it in 6 quarters since.
  • Amundi's GoodRx Holdings position peaked at $2.58M in Q1 2022.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.